Exploration of Core Genes in ACTH-Independent Macronodular Adrenal Hyperplasia

Abstract

This study explores the core genes involved in the pathogenesis of ACTH-independent macronodular adrenal hyperplasia (AIMAH), so as to provide robust biomarkers for the clinical diagnosis and treatment of this disease. Gene Expression Omnibus (GEO) database was used to obtain GSE25031 microarray dataset. R package “limma” was applied to identify differentially expressed genes (DEGs) between AIMAH and normal samples. The Database for Annotation, Visualization and Integrated Discovery (DAVID) was employed to perform Gene Ontology (GO) annotation for the DEGs, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was conducted. A protein-protein interaction network (PPI) was constructed using the STRING online website and visualized using the Cytoscape software. The key modules and hub genes were then identified. Finally, Gene Set Enrichment Analysis (GSEA) enrichment analysis was carried out to find the signaling pathways of significant clinical value in AIMAH. A total of 295 DEGs between AIMAH and healthy samples were screened out, including 164 upregulated genes and 131 downregulated genes. Combining enrichment analysis and PPI network construction, there were 5 signifiant pathways and 10 hub genes, among which 3 genes (FOS, FOSB, and DUSP1) were identified as potential core genes of clinical significance in AIMAH. In conclusion, the 3 core genes, FOS, FOSB, and DUSP1, identified here might be potential biomarkers for AIMAH, and the current study is of guiding significance for clinical diagnosis and treatment of this disease.

Key words

ACTH-independent macronodular adrenal hyperplasia - AIMAH - computational biology - genes

Publikationsverlauf

Eingereicht: 15. Januar 2022

Angenommen nach Revision: 17. März 2022

Artikel online veröffentlicht:
09. Mai 2022

• References

• 1 Hsiao HP, Kirschner LS, Bourdeau I. et al. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J Clin Endocrinol Metab 2009; 94: 2930-2937
• 2 Almeida MQ, Harran M, Bimpaki EI. et al. Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions. J Clin Endocrinol Metab 2011; 96: E728-E738
• 3 Oh H, Koh JM, Kim MS. et al. A case of ACTH-producing pheochromocytoma associated with pregnancy. Endocr J 2003; 50: 739-744
• 4 Hu WL. Adrenal cortex-medulla mixed lesions. Chin J Laparoscop Urol (Electronic Edition) 2012; 6: 84-86
• 5 Vezzosi D, Cartier D, Régnier C. et al. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol 2007; 156: 21-31
• 6 Reinhard C, Saeger W, Schubert B. Adrenocortical nodules in post-mortem series. Development, functional significance, and differentiation from adenomas. Gen Diagn Pathol 1996; 141: 203-208
• 7 Chen WX, Lin Y, Yang CH. et al. Diagnosis and treatment of 12 cases of ACTH-independent adrenal nodular hyperplasia. Chin J Endocrinol Metab 2011; 5-8
• 8 Rogoff D, Bergada I, Venara M. et al. Intermittent hyperaldosteronism in a child due to an adrenal adenoma. Eur J Pediatr 2001; 160: 114-116
• 9 Zhao X, Zhang XB, Li HZ. Screening and preliminary validation of microRNAs associated with corticotropin-independent adrenal nodular hyperplasia. Chin J Urol 2015; 36: 921-924
• 10 Romero DG, Rilli S, Plonczynski MW. et al. Adrenal transcription regulatory genes modulated by angiotensin II and their role in steroidogenesis. Physiol Genomics 2007; 30: 26-34
• 11 Takahashi H, Ikematsu K, Tsuda R. et al. Increase in dual specificity phosphatase 1, TGF-beta stimulated gene 22, domain family protein 3 and Luc7 homolog ( S. cerevisiae )-like messenger RNA after mechanical asphyxiation in the mouse lung. Leg Med (Tokyo) 2009; 11: 181-185